Skip to Main Content

Don’t believe everything you read on the internet — especially if a small, thinly traded biotech stock is involved.

So says the Securities and Exchange Commission, which charged 27 people and companies with misleading investors by pushing promotional articles without disclosing that the authors had been paid for their pumping.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.